Skip to main content
Clinical Trials/NL-OMON32669
NL-OMON32669Not yet recruitingNot Applicable

The clinical and cost-effectiveness of mindfulness based cognitive therapy (MBCT), optimal medical management (OMM) and its combination in the prevention of relapse in patients with recurrent depression. - Mindfulness, medication and its combination for recurrent depression.

niversitair Medisch Centrum Sint Radboud0 sites400 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
400

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Patients with major depressive disorder with at least three previous depressive episodes.
  • Patients have been treated with a therapeutic dose of antidepressant medication over the last 6 months.
  • Patients are currently either in full or partial remission.

Exclusion Criteria

  • Bipolar disorder
  • Any primary psychotic disorder
  • Clinically relevant neurological or other somatic illness
  • Current alcohol or drug misuse
  • Use of high dosage of benzodiazepines (>2 mg lorazepam equivalents daily)
  • Recent Electro Convulsive Therapy

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Similar Trials